News Details
MEDIA ADVISORY: NCCN to Unveil Oncology Value Tool at Oct. 16 Press Conference in San Francisco
MEDIA ONLY
Media Advisory
NCCN to Unveil Oncology Value Tool at Oct 16 Press Conference in San Francisco
Press Conference and Media Panel:
NCCN Guidelines with NCCN Evidence Blocks:
A View of the Patient-Empowered Cancer Conversation
EDITORS: For an advance view of the NCCN Evidence Blocks, contact Katie Kiley Brown at brown@nccn.org
WHEN:
Friday, October 16, 2015
11:00 AM – 12:00 PM Pacific Time – Live or WebEx
WHAT: To further empower patients to make treatment decisions in line with their values, the National Comprehensive Cancer Network (NCCN) will introduce a new infographic tool for evaluating treatment decisions [its new value initiative]—the NCCN Evidence Blocks—at a press conference at the start of the NCCN 10th Annual Congress: Hematologic Malignancies.
The new NCCN Guidelines with NCCN Evidence Blocks enable physicians and patients to speak the same language of choice and value. Robert W. Carlson, MD, Chief Executive Officer, NCCN, will demonstrate how the five key value considerations displayed in the NCCN Evidence Blocks—Efficacy, Safety, Quality and Quantity of evidence, Consistency of evidence, and Affordability—can be used to evaluate recommended interventions in cancer care.
By adding affordability to NCCN’s existing criteria of efficacy, toxicity, and evidence for evaluating treatment options, patients will be empowered to identify, alongside their physician, optimal treatment based on clinical and economic considerations that are of most value to them.
Following opening remarks, a panel of physicians and patients will discuss the challenges and benefits presented by this new physician/patient dynamic in shared decision-making.
WHO:
Moderator:
Victoria Colliver, Health Reporter, San Francisco Chronicle; Member, Association of Health Care Journalists
Panelists:
Robert W. Carlson, MD, Chief Executive Officer, National Comprehensive Cancer Network
George Somlo, MD, Professor, Department of Hematology & Hematopoietic Cell Transplantation and Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center; NCCN Guidelines Panel Member for Multiple Myeloma
Marta Nichols, Cancer Survivor and Advocate; Emeritus Board Member, Bay Area Cancer Connections; Council Member, California Breast Cancer Research Council; Vice President, Investor Relations, GoDaddy
Don Orosco, 25-year survivor of multiple myeloma; President and Chief Financial Officer, Orosco and Associates, Inc. and DBO Motor Racing Enterprises, Inc.; Internationally Recognized Vintage Racer, Automotive Historian, Specialized Vintage Race Parts Manufacturer and Owner, Monterey Speed and Sport
WHERE:
NCCN 10th Annual Congress: Hematologic Malignancies
San Francisco Marriott Marquis, 780 Mission Street, San Francisco, CA 94103
CONTACT:
Katie Kiley Brown, NCCN, brown@nccn.org
215.690.0238 (office), 610.573.3893 (cell on-site)
To register for the live event, contact Katie Kiley Brown.
To register for the WebEx, visit https://nccn.webex.com/nccn/onstage/g.php?MTID=ef52c0e04c258563df9fdb5e45ec48c4c